Zang GQ - Search Results

1

Zhang Y, Zang GQ, Tang ZH, Yu YS. Zhang Y, et al. Among authors: zang gq. Rev Inst Med Trop Sao Paulo. 2015 Jul-Aug;57(4):368. doi: 10.1590/S0036-46652015000400019. Rev Inst Med Trop Sao Paulo. 2015. PMID: 26422167 Free PMC article. No abstract available.

2

Curative effects of interferon-alpha and HLA-DRB1 -DQA1 and -DQB1 alleles in chronic viral hepatitis B.

Zang GQ, Xi M, Feng ML, Ji Y, Yu YS, Tang ZH. Zang GQ, et al. World J Gastroenterol. 2004 Jul 15;10(14):2116-8. doi: 10.3748/wjg.v10.i14.2116. World J Gastroenterol. 2004. PMID: 15237447 Free PMC article.

3

[The function of immuno-modulating on CD1a dentritic cells by IFN-alpha in chronic hepatitis B patients in vivo].

Yu YS, Tang ZH, Zang GQ. Yu YS, et al. Among authors: zang gq. Zhonghua Gan Zang Bing Za Zhi. 2005 Nov;13(11):838, 843. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 16313730 Chinese. No abstract available.

4

Expression of ICAM-1, HLA-DR, and CD80 on peripheral circulating CD1 alpha DCs induced in vivo by IFN-alpha in patients with chronic hepatitis B.

Yu YS, Tang ZH, Han JC, Xi M, Feng J, Zang GQ. Yu YS, et al. Among authors: zang gq. World J Gastroenterol. 2006 Mar 7;12(9):1447-51. doi: 10.3748/wjg.v12.i9.1447. World J Gastroenterol. 2006. PMID: 16552819 Free PMC article. Clinical Trial.

5

[Expression of anti-HBc single-chain variable fragment mediated by recombinant replication defective adenovirus in vitro].

Tang ZH, Yu YS, Ma HH, Jiang H, Xi M, Zang GQ, Yao JL. Tang ZH, et al. Among authors: zang gq. Zhonghua Gan Zang Bing Za Zhi. 2006 Aug;14(8):587-9. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16938170 Chinese.

6

Prevalence and clinical significance of SEN virus infection in patients with non A-E hepatitis and volunteer blood donors in Shanghai.

Tang ZH, Chen XH, Yu YS, Zang GQ. Tang ZH, et al. Among authors: zang gq. World J Gastroenterol. 2008 Jul 14;14(26):4204-8. doi: 10.3748/wjg.14.4204. World J Gastroenterol. 2008. PMID: 18636667 Free PMC article.

7

Enhancement of cytotoxic T lymphocyte activity by dendritic cells loaded with Tat-protein transduction domain-fused hepatitis B virus core antigen.

Chen X, Yu Y, Pan Q, Tang Z, Han J, Zang G. Chen X, et al. Acta Biochim Biophys Sin (Shanghai). 2008 Dec;40(12):996-1004. doi: 10.1111/j.1745-7270.2008.00487.x. Acta Biochim Biophys Sin (Shanghai). 2008. PMID: 19089297

8

[HBcAg-specific CTL response induced by PTD-HBcAg fusion protein to inhibit HBV replication in vitro].

Chen XH, Pan QC, Yu YS, Tang ZH, Zang GQ. Chen XH, et al. Among authors: zang gq. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Apr;25(4):289-92. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009. PMID: 19351491 Chinese.

9

CTLA4 silencing with siRNA promotes deviation of Th1/Th2 in chronic hepatitis B patients.

Yu Y, Wu H, Tang Z, Zang G. Yu Y, et al. Cell Mol Immunol. 2009 Apr;6(2):123-7. doi: 10.1038/cmi.2009.17. Cell Mol Immunol. 2009. PMID: 19403062 Free PMC article.

10

The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice.

Chen X, Lai J, Pan Q, Tang Z, Yu Y, Zang G. Chen X, et al. Vaccine. 2010 May 21;28(23):3913-9. doi: 10.1016/j.vaccine.2010.03.070. Epub 2010 Apr 13. Vaccine. 2010. PMID: 20394723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters